Liver transplantation: The effect of new HCV drugs on liver transplantation outcomes

Nature Reviews Gastroenterology and Hepatology

Volumn 12, Issue 10, 2015, Pages p559-

  Samuel, Didier ^a   Duclos Vallée, Jean Charles ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON; RIBAVIRIN; SOFOSBUVIR;

CAUSE OF DEATH; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG SAFETY; GRAFT FAILURE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FIBROSIS; LIVER TRANSPLANTATION; MIXED INFECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; SURVIVAL RATE; COMPLICATION; END STAGE LIVER DISEASE; FEMALE; MALE; STATISTICS AND NUMERICAL DATA;

COINFECTION; END STAGE LIVER DISEASE; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER TRANSPLANTATION; MALE;

EID: 84942985655     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2015.165     Document Type: Review

References (10)

1. Samuel, D. et al. Are HIV infected patients candidates for liver transplantation? J. Hepatol. 48, 697-707 (2008).
2. Sawinsky, D. et al. Beyond the NIH multicenter HIV transplant trial experience: outcomes of HIV+ liver transplant recipients compared to HCV+ or HIV+/HCV+ coinfected recipients in the United States. Clin. Inf. Dis. http:// dx.doi.org/10.1093/cid/civ471.
3. Duclos-Vallee, J. C. et al. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 47, 407-417 (2008).
4. Miro, J. M. et al. Outcome of HCV/HIV coinfected liver transplant recipients: a prospective and multicenter cohort study. Am. J. Transplant. 12, 1866-1876 (2012).
5. Antonini, T. M. et al. Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients - usefulness of early markers after liver transplantation. Am. J. Transplant. 11, 1686-1695 (2011).
6. Tateo, M. et al. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity. AIDS 23, 1069-1076 (2009).
7. Coilly, A. et al. Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience. J. Hepatol. 60, 78-86 (2014).
8. Castells, L. et al. Pegylated Interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study. J. Hepatol. 62, 92-100 (2015).
9. Charlton, M. et al. Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced disease. Gastroenterology http://dx.doi.org/10.1053/ j.gastro.2015.05.010.
10. Antonini, T. et al. P0804: Efficacy of sofosbuvir-based treatment regimens in HIV/HCV co-infected patients after liver transplantation: The ANRS CO23 CUPILT study. J. Hepatol. 62 (Suppl. 2), S635-S636 (2015).